<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101235742</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32212</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Med Genet B Neuropsychiatr Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Med. Genet. B Neuropsychiatr. Genet.</journal-id>
<journal-title-group>
<journal-title>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1552-4841</issn>
<issn pub-type="epub">1552-485X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27943641</article-id>
<article-id pub-id-type="pmc">6179157</article-id>
<article-id pub-id-type="doi">10.1002/ajmg.b.32499</article-id>
<article-id pub-id-type="manuscript">NIHMS971364</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genomic Variants, Genes, and Pathways of Alzheimer’s Disease: An Overview</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Naj</surname>
<given-names>Adam C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schellenberg</surname>
<given-names>Gerard D.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<collab>for the Alzheimer’s Disease Genetics Consortium (ADGC)</collab>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Biostatistics and Epidemiology/Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA</aff>
<aff id="A2">
<label>2</label>Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA</aff>
<author-notes>
<corresp id="FN1">Address correspondence to: Adam Naj, PhD, Instructor, Department of Biostatistics and Epidemiology, Senior Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, 229 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104, <email>adamnaj@pennmedicine.upenn.edu</email>, Phone: (215) 746-4180, Fax: (215) 573-1050</corresp>
<fn fn-type="COI-statement" id="FN2">
<p>The authors have no conflicts of interest to declare.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>1</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>10</day>
<month>10</month>
<year>2018</year>
</pub-date>
<volume>174</volume>
<issue>1</issue>
<fpage>5</fpage>
<lpage>26</lpage>
<!--elocation-id from pubmed: 10.1002/ajmg.b.32499-->
<abstract>
<p id="P1">Alzheimer’s disease (AD) (MIM: 104300) is a highly heritable disease with great complexity in its genetic contributors, and represents the most common form of dementia. With the gradual aging of the world’s population, leading to increased prevalence of AD, and the substantial cost of care for those afflicted, identifying the genetic causes of disease represents a critical effort in identifying therapeutic targets. Here we provide a comprehensive review of genomic studies of AD, from the earliest linkage studies identifying monogenic contributors to early-onset forms of AD to the genome-wide and rare variant association studies of recent years that are being used to characterize the mosaic of genetic contributors to late-onset AD (LOAD), and which have identified approximately ~20 genes with common variants contributing to LOAD risk. In addition, we explore studies employing alternative approaches to identify genetic contributors to AD, including studies of AD-related phenotypes and multi-variant association studies such as pathway analyses. Finally, we introduce studies of next-generation sequencing, which have recently helped identify multiple low-frequency and rare variant contributors to AD, and discuss on-going efforts with next-generation sequencing studies to develop statistically well-powered and comprehensive genomic studies of AD. Through this review, we help uncover the many insights the genetics of AD have provided into the pathways and pathophysiology of AD.</p>
</abstract>
<kwd-group>
<kwd>Late-onset Alzheimer’s Disease (LOAD)</kwd>
<kwd>Alzheimer’s Disease (AD)</kwd>
<kwd>genome-wide association studies (GWAS)</kwd>
<kwd>next-generation sequencing</kwd>
<kwd>pathway analysis</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>